Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
HealthEquity, Inc is a health information services business based in the US. HealthEquity shares (HQY) are listed on the NASDAQ and all prices are listed in US Dollars. HealthEquity employs 3,001 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Social investors
| Latest market close | $83.12 |
|---|---|
| 52-week range | $45.82 - $93.32 |
| 50-day moving average | $78.65 |
| 200-day moving average | $77.46 |
| Wall St. target price | $89.30 |
| PE ratio | 1322.9825 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.06 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $83.12 from 2021-05-28
| 1 week (2021-07-24) | N/A |
|---|---|
| 1 month (2021-07-02) | 0.57% |
| 3 months (2021-05-04) | 11.86% |
| 6 months (2021-01-31) | N/A |
| 1 year (2020-07-31) | N/A |
|---|---|
| 2 years (2019-07-31) | N/A |
| 3 years (2018-07-31) | N/A |
| 5 years (2016-07-31) | N/A |
Valuing HealthEquity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HealthEquity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
HealthEquity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1323x. In other words, HealthEquity shares trade at around 1323x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
HealthEquity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4267. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into HealthEquity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
HealthEquity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $185.4 million.
The EBITDA is a measure of a HealthEquity's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $727.8 million |
|---|---|
| Operating margin TTM | 8.96% |
| Gross profit TTM | $415.3 million |
| Return on assets TTM | 1.42% |
| Return on equity TTM | 0.3% |
| Profit margin | 0.6% |
| Book value | $22.17 |
| Market capitalisation | $6.3 billion |
TTM: trailing 12 months
There are currently 4.0 million HealthEquity shares held short by investors – that's known as HealthEquity's "short interest". This figure is 1.3% up from 4.0 million last month.
There are a few different ways that this level of interest in shorting HealthEquity shares can be evaluated.
HealthEquity's "short interest ratio" (SIR) is the quantity of HealthEquity shares currently shorted divided by the average quantity of HealthEquity shares traded daily (recently around 441734.64480874). HealthEquity's SIR currently stands at 9.15. In other words for every 100,000 HealthEquity shares traded daily on the market, roughly 9150 shares are currently held short.
However HealthEquity's short interest can also be evaluated against the total number of HealthEquity shares, or, against the total number of tradable HealthEquity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HealthEquity's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 HealthEquity shares in existence, roughly 50 shares are currently held short) or 0.0493% of the tradable shares (for every 100,000 tradable HealthEquity shares, roughly 49 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HealthEquity.
Find out more about how you can short HealthEquity stock.
We're not expecting HealthEquity to pay a dividend over the next 12 months.
Over the last 12 months, HealthEquity's shares have ranged in value from as little as $45.82 up to $93.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HealthEquity's is 1.3678. This would suggest that HealthEquity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
